I personally am surprise that Dr Patterson came wi
Post# of 148177
But now when we have it , if it is accurate , it will be good medicine to use it for patients,
but test must be accurate otherwise it may mess up our study....
Even if so far no serious side effects with Leronlimab , dose should be as low as possible to give us best results...if possible !!!!
In cancers it may be difference , since , imo , it is impossible to measure accurately all density of CCR5 in CTC and in tumors ...but this is just imo , those researchers working miracles sometimes ....
Hopefully they be able to give us more details during CC...